| Efficacy * uptake | Healthy Life Years per capita | Luxembourg N = 124,713 | Russia N = 18,122,512 | Spain N = 10,772,263 | |||||
---|---|---|---|---|---|---|---|---|---|---|
 | Not treated | Treated | Gained | Affected individuals under treatment (n) | HLYs gained across population | Affected individuals under treatment (n) | HLYs gained across population | Affected individuals under treatment (n) | HLYs gained across population | |
CURRENT CARE: NO CONSUMER EDUCATION OR HEALTH-CARE PROFESSIONAL TRAINING | ||||||||||
 Acute management ASA 1 g or paracetamol 1 g | 0.3340 | 0.0013 | 0.0009 | 0.0004 | 70,890 | 0.0001 | 14,833,657 | 0.00012 | 4,364,748 | 0.00011 |
 Prophylaxis + acute management amitriptyline 100 mg/day + ASA 1 g or paracetamol 1 g | 0.3340 | 0.0013 | 0.0009 | 0.0004 | 0 | 0.0001 | 0 | 0.00012 | 0 | 0.00011 |
Total | Â | Â | Â | Â | 70,890 | 0.0002 | 14,833,657 | 0.0026 | 4,364,748 | 0.00022 |
HLYs FOR OVERALL POPULATION | Â | Â | Â | 112 | 23,398 | 6885 | ||||
TARGET CARE: WITH CONSUMER EDUCATION AND HEALTH-CARE PROFESSIONAL TRAINING | ||||||||||
 Acute management ASA 1 g or paracetamol 1 g | 0.4847 | 0.0013 | 0.0007 | 0.0006 | 96,263 | 0.0002 | 20,142,825 | 0.00017 | 5,926,950 | 0.00016 |
 Prophylaxis + acute management amitriptyline 100 mg/day + ASA 1 g or paracetamol 1 g | 0.4886 | 0.0013 | 0.0007 | 0.0006 | 3188 | 0.0002 | 666,981 | 0.00017 | 196,257 | 0.00017 |
Total | Â | Â | Â | Â | 99,451 | 0.0004 | 20,809,806 | 0.0026 | 6,123,207 | 0.00033 |
HLYs FOR OVERALL POPULATION | Â | Â | Â | 163 | 34,090 | 10,031 |